Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm trial of propranolol ointment for infantile hemangioma
jRCTs041190041Completed
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of propranolol in Capillary Haemangioma. Primary endpoint: Effective rate for infantile hemangioma at 24 weeks. Started Jul 2019; status: completed.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on jRCTs041190041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190041.